Clinical Trial Update: An Observational Study to Learn More About the Safety of Darolutamide in Men With Prostate Cancer in Korea

View source ↗

Summary

This is an observational study in Korea assessing the safety of darolutamide in men with prostate cancer, including non-metastatic castration-resistant and meta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Non-metastatic Castration-resistant Prostate Cancer

Drugs mentioned

• Nubeqa (darolutamide)

Snippet

Sponsor: Bayer | Conditions: Non-metastatic Castration-resistant Prostate Cancer, Metastatic Hormone-sensitive Prostate Cancer | Status: RECRUITING